115 related articles for article (PubMed ID: 6109453)
1. The need for continuous use of antiparkinsonian medication with chronic schizophrenic patients receiving long-term neuroleptic therapy.
Manos N; Gkiouzepas J; Logothetis J
Am J Psychiatry; 1981 Feb; 138(2):184-8. PubMed ID: 6109453
[TBL] [Abstract][Full Text] [Related]
2. [Antiparkinson drugs in neuroleptic treatment: comparative study of progressive and abrupt withdrawal].
Ben Hadj Ali B; Dogui M; Ben Ammou S; Lôo H
Encephale; 1995; 21(3):209-15. PubMed ID: 7649071
[TBL] [Abstract][Full Text] [Related]
3. Reversibility of long-term tardive dyskinesia associated with antiparkinsonian medication: a case report.
Good MI
Am J Psychiatry; 1981 Aug; 138(8):1112-3. PubMed ID: 6114643
[TBL] [Abstract][Full Text] [Related]
4. No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients.
Silver H; Geraisy N; Schwartz M
J Clin Psychiatry; 1995 Apr; 56(4):167-70. PubMed ID: 7713856
[TBL] [Abstract][Full Text] [Related]
5. Discontinuing antiparkinson medication in chronic schizophrenics. At what cost to the patient?
Manos N; Gkiouzepas J
Acta Psychiatr Scand; 1981 Jan; 63(1):28-32. PubMed ID: 6112842
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of antiparkinsonian drugs during neuroleptic treatment and the effect of clonazepam on akathisia and parkinsonism occurred after antiparkinsonian drug withdrawal: a double-blind study.
Horiguchi J; Nishimatsu O
Jpn J Psychiatry Neurol; 1992 Sep; 46(3):733-9. PubMed ID: 1362592
[TBL] [Abstract][Full Text] [Related]
7. Differential memory function with dopaminergic versus anticholinergic treatment of drug-induced extrapyramidal symptoms.
Fayen M; Goldman MB; Moulthrop MA; Luchins DJ
Am J Psychiatry; 1988 Apr; 145(4):483-6. PubMed ID: 2894780
[TBL] [Abstract][Full Text] [Related]
8. Rabbit syndrome--a rare complication of long-term neuroleptic medication.
Deshmukh DK; Joshi VS; Agarwal MR
Br J Psychiatry; 1990 Aug; 157():293. PubMed ID: 1977486
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the need for prophylactic antiparkinsonian medication in psychotic patients treated with neuroleptics.
Manos N; Lavrentiadis G; Gkiouzepas J
J Clin Psychiatry; 1986 Mar; 47(3):114-6. PubMed ID: 2869027
[TBL] [Abstract][Full Text] [Related]
10. Withdrawal of trihexyphenidyl.
McInnis M; Petursson H
Acta Psychiatr Scand; 1985 Mar; 71(3):297-303. PubMed ID: 3984771
[TBL] [Abstract][Full Text] [Related]
11. Drug levels and antiparkinsonian drugs in neuroleptic-treated schizophrenic patients.
Hitri A; Craft RB; Sethi R; Sinha D
Clin Neuropharmacol; 1987 Jun; 10(3):261-71. PubMed ID: 2900683
[TBL] [Abstract][Full Text] [Related]
12. [A double-blind study on the effect of dexetimide in the control of neuroleptic-induced extrapyramidal side-effects].
Chen Y
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Aug; 24(4):197-9, 251. PubMed ID: 1683277
[TBL] [Abstract][Full Text] [Related]
13. Tardive dyskinesia in chronic schizophrenic inpatients.
Kua EH; Ang PC; Siew HC
Singapore Med J; 1982 Feb; 23(1):19-21. PubMed ID: 6126008
[No Abstract] [Full Text] [Related]
14. A placebo-controlled trial of trihexyphenidyl in unmedicated patients with schizophrenia.
Goff DC; Amico E; Dreyfuss D; Ciraulo D
Am J Psychiatry; 1994 Mar; 151(3):429-31. PubMed ID: 8109654
[TBL] [Abstract][Full Text] [Related]
15. Adverse effects of antiparkinson drug withdrawal.
Jellinek T; Gardos G; Cole JO
Am J Psychiatry; 1981 Dec; 138(12):1567-71. PubMed ID: 6118066
[TBL] [Abstract][Full Text] [Related]
16. Biperiden withdrawal in schizophrenic inpatients receiving long-term antipsychotic medication.
Wada Y; Koshino Y; Yamaguchi N
Clin Neuropharmacol; 1987 Aug; 10(4):370-5. PubMed ID: 2902920
[TBL] [Abstract][Full Text] [Related]
17. Effect of antiparkinsonian medication on plasma levels of chlorpromazine.
Simpson GM; Cooper TB; Bark N; Sud I; Lee JH
Arch Gen Psychiatry; 1980 Feb; 37(2):205-8. PubMed ID: 7352851
[TBL] [Abstract][Full Text] [Related]
18. Effects of trihexyphenidyl on MMSE and CAMCOG scores of medicated elderly patients with schizophrenia.
Heinik J
Int Psychogeriatr; 1998 Mar; 10(1):103-8. PubMed ID: 9629529
[TBL] [Abstract][Full Text] [Related]
19. Absence of neuroleptic-induced parkinsonism in psychotic patients receiving adjunctive electroconvulsive therapy.
Mukherjee S; Debsikdar V
Convuls Ther; 1994 Mar; 10(1):53-8. PubMed ID: 7914462
[TBL] [Abstract][Full Text] [Related]
20. Neuroleptic withdrawal in patients meeting criteria for supersensitivity psychosis.
Singh H; Hunt JI; Vitiello B; Simpson GM
J Clin Psychiatry; 1990 Aug; 51(8):319-21. PubMed ID: 1974249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
